Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2008 R21 RFA-CA-07-033 TURCHI, JOHN J INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS DEVELOPMENT OF METHODOLOGIES FOR THE ANALYSIS OF DNA REPAIR CAPACITY TO PREDICT T Complete
2011 R21 RFA-CA-10-003 PARKER, LAURIE L. PURDUE UNIVERSITY BIOSENSOR TECHNOLOGY TO MONITOR LEUKEMIA-RELATED KINASE ACTIVITY IN PATIENT CELLS Complete
2015 R21 RFA-CA-14-003 BIRTWISTLE, MARC R ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI MULTIPLEXED, QUANTITATIVE FLUORESCENCE IMAGING IN TUMOR SECTIONS Complete
1999 R33 PAR-98-067 YATES, JOHN ROBERT UNIVERSITY OF WASHINGTON DIRECT MS ANALYSIS OF COMPLEX PROTEIN MIXTURES Complete
2001 R33 PAR-99-102 GALE, JAMES M UNIVERSITY OF NEW MEXICO MOLECULAR STAGING OF HUMAN SQUAMOUS CELL SKIN CANCER Complete
2004 R33 PAR-01-104 MUDDIMAN, DAVID C. MAYO CLINIC OVARIAN CANCER SCREENING USING COMPREHENSIVE PROTEOMICS Complete
2007 R21 RFA-CA-07-019 ANDERSON, KAREN S YALE UNIVERSITY UNIVERSAL TECHNOLOGY FOR PROFILING THE DYNAMICS OF NORMAL & ONCOGENIC SIGNALING Complete
2010 R21 RFA-CA-09-008 HAKANSSON, KRISTINA UNIVERSITY OF MICHIGAN NOVEL APPROACHES FOR STRUCTURAL DETERMINATION OF CANCER STEM CELL GLYCANS Complete
2014 R21 RFA-CA-13-003 WHITE, KEVIN P. UNIVERSITY OF CHICAGO MICRO-WESTERN ARRAY METHODOLOGY FOR ASSESSMENT OF PREANALYTICAL VARIABILITY IN BI Complete
2001 R21 PAR-99-102 PARKOS, CHARLES A EMORY UNIVERSITY PHAGE DISPLAY AND PROSTATE NEOPLASIA PROGRESSION Complete
2003 R33 PAR-01-104 ARAP, WADIH UNIVERSITY OF TEXAS MD ANDERSON CAN CTR STEM CELL-BRAIN TUMOR INTERPLAY & IN VIVO PHAGE DISPLAY Complete
2006 R43 RFA-CA-06-005 GELLIBOLIAN, ROBERT N-ABL THERAPEUTICS, INC. MEASURING C-ABL ACTIVITY IN CML USING A HIGH-AFFINITY NANOSENSOR Complete
2009 R21 RFA-CA-08-007 ZENG, GANG UNIVERSITY OF CALIFORNIA LOS ANGELES AUTO-ANTIBODY PLUS PSA ASSAY FOR PATIENTS WITH PROSTATE CANCER Complete
2013 R21 RFA-CA-13-001 OZERS, MARY SZATKOWSKI PROTEOVISTA, LLC HIGH DENSITY PEPTIDE ARRAYS FOR CANCER-RELATED POST-TRANSLATIONAL MODIFICATIONS Complete
2016 R33 RFA-CA-15-005 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA VALIDATION OF A ROOM-TEMPERATURE STORAGE TECHNIQUE FOR PLASMA/SERUM BIOSPECIMENS Complete
2021 R21 CA20-017 HOSHIKA, SHUICHI FOUNDATION FOR APPLIED MOLECULAR EVOLUTN High Quality Proteins with Multiple Post Translational Modifications Completed
2021 R21 CA20-017 DI CARLO, DINO UNIVERSITY OF CALIFORNIA LOS ANGELES Lab on a particle technology for functional screening of therapeutic cells Completed
2021 R21 CA20-019 NAUTIYAL, SHIVANI PRIME GENOMICS, INC. Device for Preservation of Cell Free RNA in Saliva Completed
2021 R21 CA20-019 AKSAN, ALPTEKIN UNIVERSITY OF MINNESOTA Novel cryopreservation method for stabilization of manufactured therapeutic cells Completed
2021 R21 CA20-017 BHARGAVA, ROHIT UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN Spectroscopy Assisted Laser Microdissection Completed
2021 R33 CA20-018 ZENG, YONG UNIVERSITY OF FLORIDA Integrative Functional Profiling of Tumor-Derived Extracellular Vesicles Completed
2021 R33 CA20-018 JIANG, NING JENNY UNIVERSITY OF PENNSYLVANIA A streamlined, high-throughput platform for validation of cancer antigen presentation and isolation of cancer antigen reactive T cells Completed
2021 R33 CA20-018 WEI, WEI INSTITUTE FOR SYSTEMS BIOLOGY Liquid biopsy-based toolkits for neoantigen and cognate TCR discovery for cancer immunotherapy Completed
2021 R33 CA20-018 CHENG, JI-XIN BOSTON UNIVERSITY (CHARLES RIVER CAMPUS) Mapping Cancer Metabolism by Mid-infrared Photothermal Microscopy Completed
2021 R21 CA20-017 FARIS, GREGORY W NUMENTUS TECHNOLOGIES INC. Decoding Individual Exosomes in Cancer Completed
2021 R21 CA20-017 DIDENKO, VLADIMIR V BAYLOR COLLEGE OF MEDICINE In situ assay imaging nuclear RNA exosome activity for cancer studies Completed
2021 R21 CA20-017 HAINER, SARAH JANE UNIVERSITY OF PITTSBURGH AT PITTSBURGH Using nanobodies to increase the sensitivity and resolution of chromatin profiling through uliCUT&RUN Completed
2021 R21 CA20-017 DEININGER, MICHAEL W VERSITI WISCONSIN, INC. A Bioluminescent Assay for Direct Measurement of Sirtuin Activity in Cancer Cells Completed
2021 R21 CA20-017 SCHULMAN, REBECCA JOHNS HOPKINS UNIVERSITY Secretion responsive Hydrogels for Identification of Functional single T cells (SHIFT) Completed
2022 R21 CA21-005 BORGES, CHAD R ARIZONA STATE UNIVERSITY-TEMPE CAMPUS Aliquot-level visual indicators of biospecimen exposure to thawed conditions Completed
2022 R21 CA21-003 BOYLE, ALAN P UNIVERSITY OF MICHIGAN AT ANN ARBOR High-throughput inverted reporter assay for characterization of silencers and enhancer blockers Completed
2022 R21 CA21-003 SCARCELLI, GIULIANO UNIV OF MARYLAND, COLLEGE PARK Stimulated Brillouin Flow Cytometry for biomechanical assessment of metastatic potential Completed
2022 R21 CA21-003 LEE, HAKHO MASSACHUSETTS GENERAL HOSPITAL 3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids Completed
2022 R21 CA21-003 BELCHER, ANGELA M MASSACHUSETTS INSTITUTE OF TECHNOLOGY A cell-cycle induced genetic recorder for simultaneous recovery of cell divisions and lineage Completed
2022 R33 CA21-004 DRAKE, RICHARD R MEDICAL UNIVERSITY OF SOUTH CAROLINA Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids Completed
2022 R21 CA21-003 ARMITAGE, BRUCE A CARNEGIE-MELLON UNIVERSITY Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA Completed
2017 R21 RFA-CA-16-001 DICKINSON, BRYAN UNIVERSITY OF CHICAGO rePPI-i: A system for the rapid continuous evolution of protein-protein interaction inhibitors NCE
2018 R33 RFA-CA-17-011 CIMA, MICHAEL J MASSACHUSETTS INSTITUTE OF TECHNOLOGY Advanced development and validation of microdevices for high-throughput in situ drug sensitivity testing in tumors NCE
2018 R33 RFA-CA-17-011 KONRY, TANIA TALI NORTHEASTERN UNIVERSITY Determining treatment sensitivity in B cell lymphoma by novel microfluidics-based NK cell immunogenicity platform NCE
2017 R33 RFA-CA-16-004 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA Rapid unbiased isolation and in situ RNA analysis of circulating tumor cells using a magnetic micropore-based diagnostic chip NCE
2018 R33 RFA-CA-17-011 LIU, YANG UNIVERSITY OF PITTSBURGH AT PITTSBURGH High-throughput super-resolution imaging of chromatin structures at different epigenetic states NCE
2017 R33 RFA-CA-16-004 PATTENDEN, SAMANTHA GAIL UNIV OF NORTH CAROLINA CHAPEL HILL The application of Enhanced Cavitation to enable DNA and Chromatin Extraction from Archived Tissues NCE
2018 R33 RFA-CA-17-011 LU, JUN YALE UNIVERSITY CRISPR-based Enhanced Molecular Chipper Technology for Identifying Functional Noncoding Elements in Cancer NCE
2016 R21 RFA-CA-15-002 GAMCSIK, MICHAEL NORTH CAROLINA STATE UNIVERSITY RALEIGH HIGH-THROUGHPUT SCREENING UNDER STATIC OR DYNAMIC HYPOXIA NCE
2018 R33 RFA-CA-17-011 SALIPANTE, STEPHEN J UNIVERSITY OF WASHINGTON Advanced development and validation of genome-scale molecular diagnostics for microsatelliteinstability using targeted molecular counting methods NCE
2017 R33 RFA-CA-16-004 ZILBERBERG, JENNY HACKENSACK UNIVERSITY MEDICAL CENTER Ex vivo culture platform validation for preservation of patient derived multiple myeloma cells NCE
2016 R33 RFA-CA-15-003 WEISS, GREGORY A. UNIVERSITY OF CALIFORNIA-IRVINE Monitoring Recurrent Bladder Cancer with Electro-Phage Biosensors NCE
2018 R21 RFA-CA-17-012 PAULOVICH, AMANDA G FRED HUTCHINSON CANCER RESEARCH CENTER Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome NCE
2017 R33 RFA-CA-16-002 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INST Maximum efficiency sequencing using nuclease-based mutation enrichment and digital barcodes NCE
2016 R33 RFA-CA-15-003 LIN, QIAO COLUMBIA UNIV NEW YORK MORNINGSIDE Validating Rapid Microfluidic Isolation of Personalized Aptamers for Monitoring Minimal Residual Disease in Multiple Myeloma NCE

Pages